Cambridge Investment Research Advisors’s Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest JHY Stock Holding History

Cambridge Investment Research Advisors’s Portfolio JHY Stock Details JHY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-11,027	Closed	-$109K	–	2439
2019 Q2	$109K	Sell	11,027 -4,838	-30%	-$48.1K	﹤0.01%	2094
2019 Q1	$158K	Buy	15,865 +5,573	+54%	+$55.6K	﹤0.01%	2128
2018 Q4	$102K	Buy	10,292 +134	+1%	+$1.31K	﹤0.01%	2033
2018 Q3	$98K	Buy	+10,158	New	+$100K	﹤0.01%	2151

Other funds holding JHY

IWC

Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 16.21% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Cambridge Investment Research Advisors's JHY Position: Q3 2019 in Review

Cambridge Investment Research Advisors sold out of Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest (JHY) in Q3 2019, closing a stake of 11,027 shares — an estimated $109K sold.

Cambridge Investment Research Advisors first reported a position in JHY in Q3 2018 and held it in 4 quarters. The position peaked at $158K in Q1 2019. 25 funds tracked by Wall St. Rank hold JHY as of Q3 2019.

Cambridge Investment Research Advisors reported no remaining Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest position as of Q3 2019 after selling out during the quarter.
Cambridge Investment Research Advisors sold 11,027 Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest shares in Q3 2019, an estimated $109K.
Cambridge Investment Research Advisors first reported a position in Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest in Q3 2018 and held it in 4 quarters.
Cambridge Investment Research Advisors's Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest position peaked at $158K in Q1 2019.
25 funds tracked by Wall St. Rank held Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest as of Q3 2019.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2019, filed 28 Oct 2019.